AMR: Ambitious initiatives of the U.S. government
01.02.2016
The Centers for Disease Control and Prevention (CDC) estimates that each year at least two million illnesses and 23.000 deaths are caused by drug-resistant bacteria
The Centers for Disease Control and Prevention (CDC) estimates that each year at least two million illnesses and 23.000 deaths are caused by drug-resistant bacteria
In the recently published study “Alternatives to antibiotics – a pipeline portfolio review” (The Lancet, 12 January 2016) the scientists demonstrate the ten most promising
Why are cross-border initiatives in the fight against AMR so important? We asked Prof. Alexander Friedrich, chair of the Department of Medical Microbiology and Infection
A recently published report from Eurosurveillance (Nov. 12) about carbapenemase producing enterobacteriaceae (CPE) in Europe states: Cases of this germs are showing a sharp rise.
HAIs have a huge economic burden. In a report from the WHO and also according to a report from the ECDC, these infections account for
“It´s high time for an International Patient Safety Day”, thought the relevant institutions of the three countries Austria, Switzerland and Germany – and initiated one.
The famous jazz singer Ingrid Sertso survived MRSA-Infection. Her story shows us, that the possibility to get infected in hospitals is extremely high. On September
The head of the regional health insurance company “Wiener Gebietskrankenkasse” (WGKK), Ingrid Reischl, recently requested more primary health care centres (currently exists only one), which
Researchers of the AIT Austrian Institute of Technology develop rapid and cost-effective options for diagnosing life-threatening infectious diseases. An interview with Dr. Ivan Barisic, scientist
„The need to share knowledge and experience remains unchanged“ said ICPIC chairman Prof. Didier Pittet at the third ICPIC conference in Geneva on June 16-19.